Covington is one of the few venture investors that support their entrepreneurs 110% making them a truly vested partner in the success of the business and the people behind it.
Sean McCann - CEO, MMIST
Covington had the patience and long term commitment to support SXC through its early years and continues to support the Company at the Board level. Their continued participation has enabled Covington to remain involved in SXC during a period of unprecedented growth supporting an outstanding venture capital return and true Canadian technology success story.
Jeff Park, EVP and CFP, SXC
Covington understands both the North American investment landscape and the complexities of our business which makes them an ideal financial partner for Interface in the complex world of biomedical investing.
Interface Biologics, CEO